In other tumors (i.e. skin cancer, hepatocarcinoma, multiple myeloma, and acute myeloid leukemia), SIRT6 can act as a tumor promoter and its overexpression has been associated to poor outcomes21–23. The gene discussed is SIRT6; the disease is neoplasm.